Comparative Biowaiver Study of Moxifloxacin in Immediate Release of Oral Solid Dosage Form
Zahid Siraj,
Omair Adil,
Bakht Amin
et al.
Abstract:Biowaiver is based on a Bio-pharmaceutical Classification System (BCS), and it is used to waive in-vivo studies of test products that are intended for registration from drug regulatory authorities. After certain in-vitro testing, the BCS tells whether the test product is “bioequivalent” to the reference or innovator product or not. Bioequivalence is needed to check the risks arising from the presence of different excipients in the formulation and due to manufacturing variables being deemed to be low. Moxifloxa… Show more
Set email alert for when this publication receives citations?
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.